Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertuzumab & Trastuzumab According to Estrogen Receptor and HER2 Expression"
By
Insights from 2023 SABCS
FEATURING
Elisa Agostinetto
By
Insights from 2023 SABCS
FEATURING
Elisa Agostinetto
293 views
December 13, 2023
Comments 0
Login to view comments.
Click here to Login
Videos